June 2025

Akpanekpo E.I., Butler T., Srasuebkul P., Trollor J., Kasinathan J.G., Greenberg D., Schofield P., Kenny D.T., Gaskin C., Simpson M., Jones J., Ekanem A.M. (2025). Mental health disorders, adverse childhood experiences and accelerated reoffending among justice-involved youth in Australia: A longitudinal recurrent event analysis. International Journal of Law and Psychiatry, 101. DOI: 10.1016/j.ijlp.2025.102099

Artenie A., Trickey A., Looker K.J., Stone J., Lim A.G., Fraser H., Degenhardt L., Dore G.J., Grebely J., Cunningham E.B., Hazarizadeh B., Low-Beer D., Luhmann N., Webb P., Hickman M., Vickerman P. (2025). Global, regional, and national estimates of hepatitis C virus (HCV) infection incidence among people who inject drugs and number of new annual HCV infections attributable to injecting drug use: a multi-stage analysis. The Lancet Gastroenterology and Hepatology, 10(4), pp. 315-331. DOI: 10.1016/S2468-1253(24)00442-4

Babor T.F., Adinoff B., Clark L., Crockford D., Demetrovics Z., Dietze P., Fallu J., Gainsbury S., Gilchrist G., Gorelick D.A., Graham K., Grebely J., Heim D., Hellman M., Laslett A.L., McCuistian C., Miovsky M., Morojele N.K., Moskalewicz J., Obot I., Pates R., Room R., Rychert M., Sultan A., Treloar C., Turner N.E., Wells S., Williams E.C., Witkiewitz K. (2025). A clarion call to the addiction science community: It's time to resist the anti-scientific policies of the US Trump administration. Journal of Behavioral Addictions. DOI: 10.1556/2006.2025.00033

Babor T.F., Adinoff B., Clark L., Crockford D., Demetrovics Z., Dietze P., Fallu J., Gainsbury S., Gilchrist G., Gorelick D.A., Graham K., Heim D., Hellman M., Laslett A.L., McCuistian C., Miovsky M., Morojele N.K., Moscalewicz J., Obot I., Pates R., Room R., Rychert M., Sultan A., Treloar C., Turner N.E., Wells S., Williams E.C., Witkiewitz K., Grebely J. (2025). A clarion call to the addiction science community: It's time to resist the anti-scientific policies of the US Trump administration. Nordic Studies on Alcohol and Drugs. DOI: 10.1177/14550725251325970

Bahceci D., Siefried K., Steele M., Harrod M., Bell G., Barratt M.J., Nicholas C.R., Rodgers A., Hendricks P.S., Stauffer C.S., Liknaitzky P., Brett J. (2025). Exploring psychedelic experiences among people who regularly use methamphetamine: Findings from an international survey. Drug and Alcohol Dependence, 272, art. no. 112699. DOI: 10.1016/j.drugalcdep.2025.112699

Bartlett B., Sanfilippo F.M., Lee S., Ludewick H., Waterer G., Rajwani A., Bharat C., Ihdayhid A.R., Corrales-Medina V., Dwivedi G. (2025). The Risk of Adverse Cardiac Events after Pneumonia in Patients with Coronary Artery Disease. Annals of the American Thoracic Society, 22(6), pp. 855-862. DOI: 10.1513/AnnalsATS.202407-714OC

Bartram A., Ahad M.A., Long A., Lubman D., Morrison E., Rundle J., Lee N., Wilson S., Bowden J. (2025). ‘It's Hard to Look Past the Accessibility’: Service Provider Perspectives on Implementing Telehealth for Alcohol and Other Drug Counselling as a Health Service Innovation. Drug and Alcohol Review. DOI: 10.1111/dar.70000

Beck S.A., Barlow C., Engel L., Barratt M.J. (2025). “Wood-lover paralysis”: Describing a toxidrome with symptoms of weakness caused by some lignicolous “wood-loving” Psilocybe mushrooms. Toxicon, 264, art. no. 108450. DOI: 10.1016/j.toxicon.2025.108450

Booth K., Roberts-Barker K., Foster J., Getnet Mersha A., Maddox R., Bonevski B., Chamberlain C., Clarke K., Segan C., Kennedy M. (2025). “It’s changed my life. I’m not smoking anymore. I don’t want to smoke anymore”: Exploring the acceptability of mailout smoking cessation support for and by Aboriginal and Torres Strait Islander People. Nicotine and Tobacco Research, 27(3), pp. 398-407. DOI: 10.1093/ntr/ntae065

Broady T., Drysdale K., Brener L., Schroeder S., Marshall A.D., Lafferty L., Higgs P., Baldry E., Dietze P., Stoove M.A., Treloar C. (2025). Using theory-informed, arts-based research translation to change community attitudes towards people who inject drugs newly released from prison: A randomised controlled trial. Public Health, 242, pp. 103-110. DOI: 10.1016/j.puhe.2025.02.025

Chandrasena U, Peacock A, Sutherland R. Barriers to accessing prescription cannabis among two samples of people who regularly use drugs, nationally, 2024. Drug Trends Bulletin Series. Sydney: National Drug and Alcohol Research Centre, UNSW Sydney; 2025. DOI: 10.26190/unsworks/30962.

Chandrasena U, Peacock A, Sutherland R. Prescribed e-cigarette use and access among two samples in Australia who regularly use illicit drugs, 2022-2024. Drug Trends Bulletin Series. Sydney: National Drug and Alcohol Research Centre, UNSW Sydney; 2025. DOI: 10.26190/unsworks/31005

Conigrave J., Dobbins T., Buckley N.A., Lee K.S., Morley K.C., Doyle M.F., Al-Ansari B., Wilson S., Loggins S., Conigrave K. (2025). Disparities in Opioid Agonist Treatment Accessibility for Priority Populations in New South Wales, Australia. Drug and Alcohol Review, 44(4), pp. 975-982. DOI: 10.1111/dar.14069

Conroy D., Bartram A. (2025). Wide-Ranging Responses to Temporary Abstinence Challenges Among UK-Based Heavier Drinkers: A Three-Wave Longitudinal Interpretative Phenomenological Analysis. Qualitative Health Research, 0(0). DOI: 10.1177/10497323251320913

Dangardt F., Holder H., Naimi T.S., Stockwell T.R., Andreasson S., Chikritzhs T.N. (2025). Alcohol and Society 2025: Health and Social Benefits from Reduced Alcohol Consumption: When Less is More. Svensk sjuksköterskeförening, SFAM, SAFF, CERA, IOGT i Norge, Hjärnfonden, Movendi International, SLAN, Junis, UNF & IOGT-NTO, Stockholm. ISBN: 978-91-988422-8-9

Darke S., Duflou J., Peacock A., Lim J., Havard A., Farrell M., Lappin J. (2025). Characteristics of deaths related to lithium toxicity in Australia, 2000–2024. Australian and New Zealand Journal of Psychiatry. DOI: 10.1177/00048674251336037

Dawe J., Wilkinson A., Curtis M., Asselin J., Henderson C., Makoni E., Dietze P., Hellard M., Stoove M.A. (2025). Changing patterns of opioid agonist therapy prescribing in a network of specialised clinics providing care to people with opioid use disorder in Victoria, Australia, 2015 to 2023. Drug and Alcohol Review. DOI: 10.1111/dar.14049

Deans E., Yuen W.S., Economidis G., Shakeshaft A., Farnbach S. (2025). A mixed methods evaluation of an alcohol and other drug psychoeducation program for clients with complex support needs. Evaluation and Program Planning, 111, art. no. 102578. DOI: 10.1016/j.evalprogplan.2025.102578

Deans E., Yuen W.S., Economidis G., Shakeshaft A., Farnbach S. (2025). Understanding the unique goals of complex support clients accessing alcohol and other drug treatment. BMC Health Services Research, 25(1), art. no. 494. DOI: 10.1186/s12913-025-12559-2

Di Censo G., Thompson K., Bowden J. (2025). Alcohol and other drug use by Australian workers: insights from a nationally representative cross-sectional survey. Health Promotion International, 40(2), daaf048. DOI: 10.1093/heapro/daaf048

Ding D., Tarp J., Giovannucci E., Clare P.J. (2025). Causal inference in physical activity epidemiology research: An opportunity for better evidence. British Journal of Sports Medicine, art. no. 109102. DOI: 10.1136/bjsports-2024-109102

Doran C.M., Bryant J., Langham E., Bainbridge R., Shakeshaft A., Hobden B., Farnbach S., Freund M. (2025). Psychometric properties, and cultural appropriateness, of patient reported outcome measures for use in primary healthcare: a scoping review. Quality of Life Research, art. no. e0191747. DOI: 10.1007/s11136-025-03956-5

Ezard N., Clifford B., Siefried K.J., Ali R., Dunlop A., McKetin R., Bruno R., Carr A., Ward J., Farrell M., Graham R., Haber P., Lubman D., Donoghoe M.W., Olsen N., Baker A., Hall M., Arunogiri S., Lintzeris N., Gill A., Rodgers C., Montebello M., Liaw W., Liu Z. (2025). Lisdexamfetamine in the treatment of methamphetamine dependence: A randomised, placebo-controlled trial. Addiction, 120(7), pp. 1345-1359. DOI: 10.1111/add.16730

Ezard N., Siefried K.J., Clifford B. (2025). Commentary on Young et al.: Clinical guidance is required for stimulant co-prescription with opioid agonist therapy. Addiction, 120(6), pp. 1195-1197. DOI: 10.1111/add.70061

Fischer J.A., Thompson K., Muminovic A., McLaren H. (2025). Visibility of alcohol and other drug subjects and careers provided by Australian social work programs. Journal of Social Work Practice in the Addictions, pp. 1-12. DOI: 10.1080/1533256X.2025.2480323  

Fursman H., Brown J.A., Riseley R., Silins E., Bartlett M., Latimer J., Chadwick S., Roux C., Morelato M. (2025). Investigating drug trends among people who inject drugs: Temporal, geographical and operational analyses of used syringes in Sydney, Australia. International Journal of Drug Policy, 140, art. no. 104803. DOI: 10.1016/j.drugpo.2025.104803

Gates P., Deans E., Farnbach S. (2025). Report: A Taskforce approach to address youth vaping: Perspectives from members and stakeholders of the North Coast Youth Vaping Taskforce. Sydney: National Drug and Alcohol Research Centre, UNSW Sydney.

Getnet Mersha A., Bonevski B., Maddox R. (Bagumani), Chamberlain C. (Palawa), Clarke K. (Worimi/Gamilaroi), Forster J. (Worimi), Barker K.R. (Wiradjuri), Booth K., Segan C., Kennedy M. (Wiradjuri) (2025). Aboriginal and Torres Strait Islander People Who Smoke and Want to Quit - A Cohort Profile From the Koori Quit Pack study. Nicotine and Tobacco Research, 27(3), pp. 408-417. DOI: 10.1093/ntr/ntae213

Gide D.N., El-Den S., O'Donnell L.K., Ou K., Diamandis S., Gisev N., O'Reilly C.L. (2025). Evaluation of a training program to support depression screening for older adults in community pharmacies. Currents in Pharmacy Teaching and Learning, 17(6), art. no. 102340. DOI: 10.1016/j.cptl.2025.102340

Greenwood C.J., Foulds J., McKetin R., Aarsman S.R., Hutchinson D., Kerr J., Heerde J.A., Toumbourou J.W., Boden J.M., Slade T., Bonomo Y., Letcher P., Olsson C.A. (2025). Amphetamine use and mental health difficulties across adolescence and young adulthood: An integrative data analysis of four Australasian cohort studies. Addiction. DOI: 10.1111/add.70033

Greenwood C.J., Letcher P., Macdonald J.A., Hutchinson D.M., Youssef G.J., Toumbourou J.W., Spry E., Sanson A., Cleary J., Olsson C.A. (2025). Illicit Substance Use and Harm in Young Adulthood: the Role of Substance Use in Close Relationships and Individual Social Skills. International Journal of Mental Health and Addiction, 23(2), pp. 1503-1517. DOI: 10.1007/s11469-023-01181-0

Griffin S., Walker S., Holmes J.A., Reid B., Callus A., Belzer M., Dicka J., Papaluca T., Craigie A., Schroeder S., Lancaster K., Hellard M., Stoove M.A., Thompson A., Winter R. (2025). "Quick, simple, and friendly": Understanding the acceptability and accessibility of a nurse and peer-led, mobile model of hepatitis C care adjacent to community corrections in Australia. International Journal of Drug Policy, 139. DOI: 10.1016/j.drugpo.2025.104785

Gústafsson B.J., Puljević C., Davies E.L., Barratt M.J., Ferris J., Winstock A., Piatkowski T. (2025). Sweating for Sobriety: Exploring the Relationship Between Exercise Engagement and Substance Use Disorders. Journal of Psychoactive Drugs, 57(2), pp. 223-233, DOI: 10.1080/02791072.2024.2311143

Harrison N.J., Riddiford-Harland D., York S., Marshall H.M., Rhee J.J., Stone E., Yap M.L., Sharman A.R., Weber M., McCullough S.A., Byrne T., Paul C.L., Bowden J.A., Bonevski B., Rankin N.M. (2025). ‘Every Touch Point Is an Opportunity’: Tobacco Control Experts' Views on How to Implement Smoking Cessation Interventions Within an Australian Lung Cancer Screening Program. Cancer Medicine, 14(10), e70963. DOI: 10.1002/cam4.70963

Hefler M. (2025). Responding to US executive orders and Trump 2.0: ideological language bans and attempts to suppress science will not obscure the tobacco epidemic’s foundations of exploitation and inequity. Tobacco Control, 34, pp. 141-142. DOI: 10.1136/tc-2025-059437

Hoek J., Waa A., Edwards R., Gregan M.J., Graham-DeMello A. (2025). Looking back and planning ahead: The tobacco endgame and controlling tobacco industry interference in Aotearoa New Zealand. Journal of the Royal Society of New Zealand, pp. 1-19. DOI: 10.1080/03036758.2025.2455498

Hopkins R.E., Campbell G., Degenhardt L., Nielsen S., Cohen M., Blyth F., Gisev N. (2025). Use of Medicare-subsidised treatment services among people prescribed opioids for chronic non-cancer pain. Public Health Research and Practice, 35(2), art. no. PU24012. DOI: 10.1071/PU24012

Houdroge F., Colledge-Frisby S., Kronfli N., Winter R., Carson J., Stoove M.A., Scott N. (2025). The costs and benefits of a prison needle and syringe program in Australia, 2025-30: a modelling study. Medical Journal of Australia. DOI: 10.5694/mja2.52640

Jones N., Ghouse F.N., Gibson A., Tran D.T., Santo T., Jr, Bharat C., Farrell M., Degenhardt L. (2025). Data Resource Profile Update: The Opioid Agonist Treatment and Safety II (OATS II) Study, 2001–22, New South Wales, Australia. International Journal of Epidemiology, 54(2), art. no. dyaf037. DOI: 10.1093/ije/dyaf037

Jones N.R., Hickman M., Bharat C., Nielsen S., Larney S., Ghouse N.F., Lappin J., Degenhardt L. (2025). Identifying key risk factors for intentional self-harm, including suicide, among a cohort of people prescribed opioid agonist treatment: A predictive modelling study. Addiction. DOI: 10.1111/add.70095

Karlsson A, Peacock A & Sutherland R. Patterns of non-prescribed cannabis use among two samples of people who regularly use drugs in Australia, 2014-2024. Drug Trends Bulletin Series. Sydney: National Drug and Alcohol Research Centre, UNSW Sydney; 2025. DOI: 10.26190/unsworks/31004

Kelly P.J., Deane F.P., Baker A.L., Townsend C., McKay J.R., Degan T.J., Nolan E., Palazzi K., Byrne G., Osborne B., Meyer J., Robinson L., Oldmeadow C., Lawson K., Searles A., Lunn J., Nunes J., Ingram I. (2025). The continuing care project: A multi-arm randomised controlled trial of a continuing care telephone intervention following residential substance use treatment. Drug and Alcohol Dependence, 272, art. no. 112668. DOI: 10.1016/j.drugalcdep.2025.112668

Kennedy M., Maddox R., Getnet Mersha A., Chamberlain C., Segan C., Clarke K., Donaldson B., Roberts Barker K., Forster J., Booth K., Bonevski B. (2025). Koori Quit Pack: A feasibility study of a multi-component mailout smoking cessation support for Aboriginal and Torres Strait Islander people: “I would recommend it to anybody. It’s just so much easier”. Nicotine and Tobacco Research, 27(3), pp. 418-428. ntae106. DOI: 10.1093/ntr/ntae106

Keygan J., Willoughby B., Bruno R., Barratt M.J., Peacock A. (2025). Risk communication about high-dose MDMA: Impact of a hypothetical drug alert on future MDMA use. Drug and Alcohol Review, 44(4), pp. 1169-1181. DOI: 10.1111/dar.14037

Lappin J.M. (2025). Rare but relevant: Methamphetamine and Parkinson's disease. Addiction, 120(4), pp. 797-800. DOI: 10.1111/add.16695

Lawler K., Dronavalli M., Uebel H., Burns L., Bajuk B., Page A., Lee E., Dickson M., Green C., Dicair L., Eastwood J., Oei J.-L. (2025). Association between out-of-home care and mortality in children with prenatal drug exposure: a retrospective population-based cohort study. Archives of Disease in Childhood, art. no. 8474. DOI: 10.1136/archdischild-2025-328474

Lin J., Milder T.Y., Deakin C.T., de Oliveira Costa J., Havard A., Neuen B.L., Buckley N.A., Brieger D., Greenfield J.R., Jun M., Day R.O., Pearson S.-A., Falster M.O. (2025). Trends in use of sodium-glucose cotransporter 2 inhibitors among people with type 2 diabetes following hospitalisation with heart failure: A population-based study. Diabetes Research and Clinical Practice, 224, art. no. 112242. DOI: 10.1016/j.diabres.2025.112242

Livingston M., Gilmore W., Taylor N., Chikritzhs T., Yuen W.S., Howell J., Flores E., Curtis M., Dietze P. (2025). Age, period and cohort trends in hospital admissions for alcohol-related liver disease in Australia, 1993–2020. Drug and Alcohol Review, 44(4), pp. 1254-1263. DOI: 10.1111/dar.14063

Lloyd Z., Colledge-Frisby S., Taylor N., Livingston M., Jauncey M., Roxburgh A. (2025). Analyses Updated to 2022–23 on Australian Attitudes Towards Supervised Injecting Facilities. Drug and Alcohol Review. DOI: 10.1111/dar.14089

Macdonald C., Weatherburn D., Lappin J. (2025). Diversion into mental health treatment: a survey of magistrates and treatment plans. Psychiatry, Psychology and Law, 32(3), pp. 354-372. DOI: 10.1080/13218719.2024.2313985

Mammoliti E., Nielsen S., Roxburgh A. (2025). A Scoping Review of the Emergence of Novel Synthetic Opioids in Australian Drug Markets: What Does This Mean for Harm Reduction Responses? Drug and Alcohol Review. DOI: 10.1111/dar.14079

Man, N., Sutherland, R., Barratt, M. J., Bruno, R., Sadaphale, V., & Peacock, A. (2025). Trends in the availability and type of drugs sold on the internet via cryptomarkets, February 2024 - January 2025. Drug Trends Bulletin Series. Sydney: National Drug and Alcohol Research Centre, UNSW Sydney. DOI: 10.26190/unsworks/30960.

Meehan D.E., Clare P., Grunseit A., Merom D. (2025). Community-level determinants of loneliness and social isolation: a population-based cohort study across younger and older adults. Frontiers in Public Health, 13, art. no. 1526166. DOI: 10.3389/fpubh.2025.1526166

Piatkowski T., Barratt M.J., Coomber R., Gibbs N., Neumann D.L., Dunn M. (2025). Tracing the Impact of Media, Cultural Narratives, and Social Perceptions on Australia's Anabolic-Androgenic Steroid Communities. Contemporary Drug Problems. DOI: 10.1177/00914509251334958

Plever S., Kisely S., Bonevski B., McCarthy I., Anzolin M., Siskind D., Ballard E., Emmerson B., Allan J., Gartner C. (2025). Increases in delivery of a brief smoking cessation intervention following implementation of a system change intervention in community psychiatry settings. Australian and New Zealand Journal of Psychiatry, 0(0). DOI: 10.1177/00048674251340214

Powell M., Pilkington R., Ahmed T., Hanly M., Newton B.J., Lynch J.W., Dobbins T., Stewart J., Cretikos M., Havard A., Falster K. (2025). Prevalence of maternal substance use problems during pregnancy and the first 2 years of life: a whole-population birth cohort of 970 470 Australian children born 2008-2017. Journal of Epidemiology and Community Health, art. no. jech-2024-223439. DOI: 10.1136/jech-2024-223439

Price O., Maher L., Peacock A., Zolala F., Degenhardt L., Dietze P., Larney S., Agramunt S., Colledge-Frisby S., Mathers B., Lewer D., Sutherland R. (2025). Changing age profile and incidence of injecting drug use initiation among people in Australia who inject drugs: evidence from two national repeated cross-sectional studies. The Lancet Regional Health - Western Pacific, 57, art. no. 101548. DOI: 10.1016/j.lanwpc.2025.101548

Price O., Larney S., Martel-Laferrière V., Bruneau J., Harney B. (2025). Susceptibility to Hepatitis B Virus Infection Among People Who Inject Drugs in Montreal, Canada. Drug and Alcohol Review. DOI: 10.1111/dar.14091

Price O., Webb P., Grebely J., Peacock A., Medland N., Read P., Cooke E., Hickman M., Vickerman P., Degenhardt L. (2025). Sexually transmitted infection prevalence and testing coverage among people who inject drugs: A systematic review. Drug and Alcohol Dependence, 273, art. no. 112732. DOI: 10.1016/j.drugalcdep.2025.112732

Rahimi M., Lang B., Shahab L., Brown J., Palmer A., Kemper J., Bullen C., Laking G., Nosa V., Parag V., Walker N. (2025). Vaping cessation strategies and triggers for relapse amongst people from New Zealand who have vaped. Drug and Alcohol Review. DOI: 10.1111/dar.14061 

Reuter P., McKetin R. (2025). Introduction to special section on precursor control. International Journal of Drug Policy, 138, art. no. 104458. DOI: 10.1016/j.drugpo.2024.104458

Rose S., McFadden K., Harrison N.J., Dodd R., Onwuka S., Paul C., Carter-Bawa L., Brooke M., Weber M. (2025). Australia’s National Lung Cancer Screening Program – it’s time to address the stigma in the room. Health Promotion Journal of Australia, 36(2), e70011. DOI: 10.1002/hpja.70011

Siefried K.J., Hill P.L., Clifford B., Brown J., Camilleri A., Crawford S., Dessauer P., Dilkes-Franklin E., Freestone J., Gobeil J., Harrod M., Hudson S., Hull P., Lenton S., Lyons T., Oh G., Peacock A., Pierce A., Sidaway P., Soderstrom J., Tzanetis S., Ezard N. (2025). Co-design of the Australian Prompt Response Network for a public-health focused intersectoral approach to information sharing on emerging drugs of concern. Frontiers in Public Health. [In Press]

Spangaro J., Spence N., Man N., Walsh J., Cameron J., Hegarty K., Koziol-McLain J., McMahon T., Zwi A., Toole-Anstey C., Perry-Indermau A. (2025). Intimate partner violence and post-migration stressors reported by refugee women accessing settlement services. BMC Women's Health, 25(1), art. no. 167. DOI: 10.1186/s12905-025-03698-z

Sutherland R., Steele M., Rodgers C., Silins E., Gilliver R., Peacock A., Barratt M., Ezard N., Siefried K.J., Page R., Bruno R., Read P. (2025). Characteristics of take-home fentanyl test strip use and support for drug checking services among people who use heroin in Australia: learnings for an increasingly complex drug market. Harm Reduction Journal, 22(1), art. no. 75. DOI: 10.1186/s12954-025-01205-z

Symes E., Derrick N., Hicks T., Ross-Browne R., Degenhardt L., Sutherland R., Seimon R., Dinh M. (2025). Emergency department presentations by trans and gender diverse people in Sydney, Australia: Retrospective case series. EMA - Emergency Medicine Australasia, 37(2), art. no. e70031. DOI: 10.1111/1742-6723.70031

Symons M., Gilmore W., Henrickson N., Chikritzhs T.N. (2025). Are alcohol restrictions bad for tourism? An exploratory study of tourism trends in Western Australia. Australian and New Zealand Journal of Public Health. [In Press]

Tayeb H, Peacock A, Sutherland R. Methamphetamine use among people accessing opioid access treatment in Australia, 2014-2024. Drug Trends Bulletin Series. Sydney: National Drug and Alcohol Research Centre, UNSW Sydney; 2025. DOI: 10.26190/unsworks/31125

Taylor N., Baldwin R., Vieira E., Livingston M. (2025). Thou doth protest too much: How the minimum unit price affected retailers' revenue. Drug and Alcohol Review. DOI: 10.1111/dar.14041

Teague S.J., Shatte A.B.R., Fuller-Tyszkiewicz M., Hutchinson D.M. (2025). Mobile app-based intervention for paternal perinatal depression, anxiety, and stress: A randomised controlled trial. Journal of Affective Disorders, 382, pp. 325-335. DOI: 10.1016/j.jad.2025.04.075

Teague S.J., Shatte A.B.R., Fuller-Tyszkiewicz M., Hutchinson D.M. (2025). User-centred design and evaluation of an mHealth app for fathers’ perinatal mental health: a feasibility, acceptability, and usability study. Behaviour and Information Technology. DOI: 10.1080/0144929X.2025.2502474

Thal S., Bright S.J., Ntoumanis N., Myers-Franchi B., Jones J., Quested E. (2025). A Co-design approach to develop a motivational intervention to promote physical activity engagement and maintenance among individuals in residential substance use disorder treatment settings. Psychology of Sport and Exercise, 78. DOI: 10.1016/j.psychsport.2025.102829

Tran A.D., Chen R., Sara G., McKetin R. (2025). Health-care costs among people who use methamphetamine in Australia. Drug and Alcohol Review, 44(4), pp. 1157-1168. DOI: 10.1111/dar.14043

Tran D.T., Cohen J.M., Donald S., Cesta C.E., Furu K., Parkin L., Pearson S.-A., Reutfors J., Robijn A.L., Zoega H., Zwar N., Havard A. (2025). Risk of Major Congenital Malformations Following Prenatal Exposure to Smoking Cessation Medicines. JAMA Internal Medicine, 185(6), pp. 656-667. DOI: 10.1001/jamainternmed.2025.0290

Uporova J, Peacock A, Sutherland R. Drug detection dog encounters and precautionary behaviours at Australian music festivals among people who regularly consume illicit stimulants in Australia, 2024. Drug Trends Bulletin Series. Sydney: National Drug and Alcohol Research Centre, UNSW Sydney; 2025. DOI: 10.26190/unsworks/31119

Utrilla M.G., Chesney E., Neale J., Metrebian N., Kalk N., Skulberg A.K., Dietze P., Smith M., Strang J. (2025). Naloxone dosing in the era of synthetic opioids: Applying the Goldilocks principle. Addiction. DOI: 10.1111/add.70060

Van Der Helder S., Siefried K.J., Acheson L., Steele M., Harrod M.E., Brett J. (2025). Exploring the perceived usefulness of integration support after naturalistic psychedelic experiences in people concerned about their substance use: A survey. Journal of Psychedelic Studies. DOI: 10.1556/2054.2025.00422

Wardle F., Piatkowski T., Clifford S., Peacock A., Dietze P., Lim M., Douglass C., Hill P., Moore S., Miller M., Brett J., Wright C.J.C. (2025). Safe beats down under: investigating the support of drug checking at a regional festival in the Northern Territory, Australia. Drugs: Education, Prevention and Policy, 32(3), pp. 211-219. DOI: 10.1080/09687637.2024.2330938

Weatherburn D., Doyle M., Weatherall T., Teperski A. (2025). Does adjusting for legal factors make the racial gap in imprisonment risks disappear? Journal of Criminology, art. no. 26338076251329689. DOI: 10.1177/26338076251329689

Welch S., Purcell-Khodr G., Deweerd P., Moles R., Viardot A., Daly S., Lee K.S. (2025). Working together to ensure research conducted with Aboriginal and/or Torres Strait Islander Peoples is culturally appropriate illustrated using a pharmacy-intervention study. Journal of Pharmacy Practice and Research. DOI: 10.1002/jppr.70008

Wheeler A., Masters J., Pradhan A., Roth J.M., Degenhardt L., Dore G.J., Matthews G.V., Cunningham E.B., Peacock A., Colledge-Frisby S., Grebely J., Hajarizadeh B., Martinello M. (2025). Prevalence of Injection-Related Bacterial and Fungal Infection Among People Who Inject Drugs: A Systematic Review and Meta-analysis. Open Forum Infectious Diseases, 12(4), art. no. ofaf108. DOI: 10.1093/ofid/ofaf108

Yuen W., Man N., Livingston M., Chrzanowska A., Gilmore W., Tierney L., Moran L., Peacock A. (2025). Excess alcohol-induced hospitalisations and deaths following the onset of the COVID-19 pandemic in Australia. Drug and Alcohol Review. [In Press]

Yusoff A., Sträuli B., Jones A., O’Brien P., Bowden J., Jongenelis M., Brownbill A., Stockwell T. & Pettigrew S. (2025). Suboptimal industry adherence to the design specifications of the mandatory pregnancy warning label. Australian and New Zealand Journal of Public Health, 49(3). DOI: 10.1016/j.anzjph.2025.100236

In this issue